DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/b1d6ed/bahrain_pharmaceut) has announced the addition of the "Bahrain Pharmaceuticals and Healthcare Report Q1 2011" report to their offering.
The Bahrain Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Bahrain's pharmaceuticals and healthcare industry.
In Q111, we find Bahrain moved down two places to occupy seventh position out of the 19 regional markets surveyed in the Middle East and Africa region. This adjustment now sees Bahrain placed below Kuwait and above Lebanon. Bahrains pharmaceutical rating is 52.0, which is considerably above the average of 46.4 for the region. In a global context, we see Bahrain occupy 44th position in BMIs 83 market-strong pharmaceutical universe. Although the potential returns from the market are constrained by the islands population of under1mn, the low-risk economic and political climate and strong pharmaceutical-specific regulatory framework mean that Bahrain is one of the regions most attractive markets in terms of the risks to realisation of returns category. BMI therefore forecasts that sales of prescription drugs and over-the-counter (OTC) medications are expected to grow from US$146mn in 2009 to US$156mn in 2019, representing a compound annual growth rate (CAGR) of 8.6%.
Bahrain's Minister of Health, Dr Faisal Al Hamer has pledged that several new government hospitals will be built in order to meet the needs of a growing population. The government has acknowledged that a new hospital is now required for the inhabitants of Aali, Isa Town and Riffa, while another is also needed for people living in Jaw and Askar. The Minister has also announced plans to expand the provision of primary healthcare in the country. At present, there are 23 health centres in Bahrain, a number which will be increased to 28 by the beginning of 2011.
Key Topics Covered:
- Executive Summary
- SWOT Analysis
- Pharmaceutical Business Environment Ratings
- Bahrain Market Summary
- Regulatory Regime
- Industry Developments
- Industry Forecast Scenario
- Competitive Landscape
- Company Monitor
- Country Snapshot: Bahrain Demographic Data
- Methodology
For more information visit http://www.researchandmarkets.com/research/b1d6ed/bahrain_pharmaceut